Research into biomarkers is being explored as a means to improve diagnosis of multiple sclerosis. The use of proteomics and multiomics may help clarify the disease's mechanisms. Diagnosis and treatment of multiple sclerosis are distinct, and studies are also investigating ways to reverse neuropathy, although the relationship between these developments is unclear.